Study details
Enrolling now
HARP Pilot 2 Trial
Yale University
NCT IDNCT06513819ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
100
Study length
about 12 months
Ages
50+
Locations
1 site in CT
About this study
This trial is testing a new approach called IMB-MI to help people with HIV manage their alcohol, cannabis use, and medications. The goal is to reduce falls and improve thinking skills by addressing these factors together.
Based on ClinicalTrials.gov records.
What participants do
- 1.Participate in Information Motivation Behavioral and Motivational Interviewing (IMB-MI) technique
PhasePhase 1
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low4%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Secondary: Neurocognitive symptoms mean score
Body systems
Immune, Infectious